Trials / Completed
CompletedNCT03694327
Innovative Digital Therapeutic for Smoking Cessation
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 158 (actual)
- Sponsor
- My Digital Study · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is comparing the efficacy of two smoking cessation apps.
Detailed description
Given that tobacco smoking is the leading cause of preventable death in the US, the development of effective cessation programs is critical; mobile phone applications represent a novel, accessible platform for helping smokers quit. This research project seeks to compare the efficacy of two smoking cessation apps. In a blinded, randomized, controlled study, current smokers motivated to quit will use a smoking cessation app for 8 weeks.
Conditions
- Smoking Cessation
- Nicotine Addiction
- Drug Addiction
- Drug Dependence
- Tobacco Dependence
- Tobacco Use Disorder
- Substance Use Disorder
- Tobacco Smoking
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CT-101-M | Mobile Application |
| DEVICE | QuitGuide | Mobile Application |
Timeline
- Start date
- 2018-10-24
- Primary completion
- 2019-03-14
- Completion
- 2019-03-14
- First posted
- 2018-10-03
- Last updated
- 2022-06-06
- Results posted
- 2022-06-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03694327. Inclusion in this directory is not an endorsement.